LILLY ILAC TICARET LIMITED SIRKETI

Company Profile: LILLY ILAC TICARET LIMITED SIRKETI

LILLY ILAC TICARET LIMITED SIRKETI is the Turkish subsidiary of Eli Lilly and Company, a prominent global pharmaceutical corporation. The company's core operations in Turkey involve the marketing, sales, and distribution of Eli Lilly's innovative pharmaceutical products. It is dedicated to bringing a wide array of medicines to Turkish patients across various therapeutic areas, including but not limited to oncology, diabetes, immunology, and neuroscience. As an integral part of a multinational pharmaceutical enterprise, LILLY ILAC TICARET LIMITED SIRKETI adheres to global standards for quality, ethical practices, and patient-centric healthcare, playing a significant role in enhancing healthcare access and outcomes in the Turkish market.

Business Type: Trader

LILLY ILAC TICARET LIMITED SIRKETI operates as a trader and distributor. Its primary function is the importation, marketing, sale, and distribution of pharmaceutical products within the Turkish market, which are manufactured by its parent company, Eli Lilly and Company. It does not engage in the manufacturing or production of pharmaceutical drugs itself.

Here are some of the products manufactured or marketed by LILLY ILAC TICARET LIMITED SIRKETI in Turkey:

* **Pharmaceuticals:**

* Diabetes medications (e.g., insulins, oral antidiabetic agents)

* Oncology products

* Neuroscience products (e.g., treatments for depression, ADHD)

* Immunology products

* Other prescription medicines